Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Heparin and carboxymethylchitosan metal nanoparticles: an evaluation of their cytotoxicity.

Bava A, Cappellini F, Pedretti E, Rossi F, Caruso E, Vismara E, Chiriva-Internati M, Bernardini G, Gornati R.

Biomed Res Int. 2013;2013:314091. doi: 10.1155/2013/314091. Epub 2013 Feb 18.

2.

Suspension of Fe(3)O(4) nanoparticles stabilized by chitosan and o-carboxymethylchitosan.

Zhu A, Yuan L, Liao T.

Int J Pharm. 2008 Feb 28;350(1-2):361-8. Epub 2007 Sep 6.

PMID:
17931808
3.

Synthesis and evaluation of chitosan-graft-polyethylenimine as a gene vector.

Wang X, Yao J, Zhou JP, Lu Y, Wang W.

Pharmazie. 2010 Aug;65(8):572-9.

PMID:
20824956
4.

Carboxymethyl chitosan as a matrix material for platinum, gold, and silver nanoparticles.

Laudenslager MJ, Schiffman JD, Schauer CL.

Biomacromolecules. 2008 Oct;9(10):2682-5. doi: 10.1021/bm800835e. Epub 2008 Sep 25.

PMID:
18816099
5.

The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.

Chung YI, Kim JC, Kim YH, Tae G, Lee SY, Kim K, Kwon IC.

J Control Release. 2010 May 10;143(3):374-82. doi: 10.1016/j.jconrel.2010.01.017. Epub 2010 Jan 25.

PMID:
20109508
6.

In vitro evaluation of folic acid modified carboxymethyl chitosan nanoparticles loaded with doxorubicin for targeted delivery.

Sahu SK, Mallick SK, Santra S, Maiti TK, Ghosh SK, Pramanik P.

J Mater Sci Mater Med. 2010 May;21(5):1587-97. doi: 10.1007/s10856-010-3998-4. Epub 2010 Jan 29.

PMID:
20111985
7.

Synthesis and properties of a novel methoxy poly(ethylene glycol)-modified galactosylated chitosan derivative.

Zhang T, Yu YY, Li D, Peng R, Li Y, Jiang Q, Dai P, Gao R.

J Mater Sci Mater Med. 2009 Mar;20(3):673-80. doi: 10.1007/s10856-008-3620-1. Epub 2008 Oct 24.

PMID:
18949535
8.

Cell uptake and in vitro toxicity of magnetic nanoparticles suitable for drug delivery.

Häfeli UO, Riffle JS, Harris-Shekhawat L, Carmichael-Baranauskas A, Mark F, Dailey JP, Bardenstein D.

Mol Pharm. 2009 Sep-Oct;6(5):1417-28. doi: 10.1021/mp900083m.

PMID:
19445482
9.

Sweeter but deadlier: decoupling size, charge and capping effects in carbohydrate coated bactericidal silver nanoparticles.

de Oliveira LF, Gonçalves Jde O, Gonçalves Kde A, Kobarg J, Cardoso MB.

J Biomed Nanotechnol. 2013 Nov;9(11):1817-26.

PMID:
24059081
10.

Tumor selectivity of stealth multi-functionalized superparamagnetic iron oxide nanoparticles.

Fan C, Gao W, Chen Z, Fan H, Li M, Deng F, Chen Z.

Int J Pharm. 2011 Feb 14;404(1-2):180-90. doi: 10.1016/j.ijpharm.2010.10.038. Epub 2010 Nov 16.

PMID:
21087660
11.

Iron nanoparticles from animal blood for cellular imaging and targeted delivery for cancer treatment.

Chamundeeswari M, Sastry TP, Lakhsmi BS, Senthil V, Agostinelli E.

Biochim Biophys Acta. 2013 Apr;1830(4):3005-10. doi: 10.1016/j.bbagen.2012.12.031. Epub 2013 Jan 10.

PMID:
23313166
12.

Genipin-cross-linked fucose-chitosan/heparin nanoparticles for the eradication of Helicobacter pylori.

Lin YH, Tsai SC, Lai CH, Lee CH, He ZS, Tseng GC.

Biomaterials. 2013 Jun;34(18):4466-79. doi: 10.1016/j.biomaterials.2013.02.028. Epub 2013 Mar 15.

PMID:
23499480
13.

Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin.

Bhumkar DR, Joshi HM, Sastry M, Pokharkar VB.

Pharm Res. 2007 Aug;24(8):1415-26. Epub 2007 Mar 23.

PMID:
17380266
14.

Magnetic nanocarriers of doxorubicin coated with poly(ethylene glycol) and folic acid: relation between coating structure, surface properties, colloidal stability, and cancer cell targeting.

Kaaki K, Hervé-Aubert K, Chiper M, Shkilnyy A, Soucé M, Benoit R, Paillard A, Dubois P, Saboungi ML, Chourpa I.

Langmuir. 2012 Jan 17;28(2):1496-505. doi: 10.1021/la2037845. Epub 2011 Dec 29.

PMID:
22172203
15.

Chitosan coating of copper nanoparticles reduces in vitro toxicity and increases inflammation in the lung.

Worthington KL, Adamcakova-Dodd A, Wongrakpanich A, Mudunkotuwa IA, Mapuskar KA, Joshi VB, Allan Guymon C, Spitz DR, Grassian VH, Thorne PS, Salem AK.

Nanotechnology. 2013 Oct 4;24(39):395101. doi: 10.1088/0957-4484/24/39/395101. Epub 2013 Sep 5.

16.

Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma.

Shi L, Tang C, Yin C.

Biomaterials. 2012 Oct;33(30):7594-604. doi: 10.1016/j.biomaterials.2012.06.072. Epub 2012 Jul 13.

PMID:
22796165
17.

Biocompatibility, cellular uptake and biodistribution of the polymeric amphiphilic nanoparticles as oral drug carriers.

Liu Y, Kong M, Feng C, Yang KK, Li Y, Su J, Cheng XJ, Park HJ, Chen XG.

Colloids Surf B Biointerfaces. 2013 Mar 1;103:345-53. doi: 10.1016/j.colsurfb.2012.11.012. Epub 2012 Nov 29.

PMID:
23247264
18.

Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.

Lin A, Chen J, Liu Y, Deng S, Wu Z, Huang Y, Ping Q.

Drug Dev Ind Pharm. 2009 Nov;35(11):1348-55. doi: 10.3109/03639040902939197.

PMID:
19832635
19.

Uptake and cytotoxicity of citrate-coated gold nanospheres: Comparative studies on human endothelial and epithelial cells.

Freese C, Uboldi C, Gibson MI, Unger RE, Weksler BB, Romero IA, Couraud PO, Kirkpatrick CJ.

Part Fibre Toxicol. 2012 Jul 3;9:23. doi: 10.1186/1743-8977-9-23.

20.

Chitosan-Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study.

Hosseinzadeh H, Atyabi F, Dinarvand R, Ostad SN.

Int J Nanomedicine. 2012;7:1851-63. doi: 10.2147/IJN.S26365. Epub 2012 Apr 11.

Items per page

Supplemental Content

Write to the Help Desk